Laurie Toich, Assistant Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Study finds high unmet need among patients with uncontrolled gout.

Biomarker identification may improve abatacept (Orencia) treatment for rheumatoid arthritis.

Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.

Elevated levels of high-density lipoprotein may not be beneficial for the heart.

Trastuzumab monotherapy was not linked to surgical complications among patients with breast cancer undergoing reconstruction after a mastectomy.

Hospital groups say that changes to the 340B program threaten access to treatment for Medicare beneficiaries.

Current treatment options for dermatomyositis may be ineffective for some patients, according to a study presented at the American College of Rheumatology Annual Meeting.

Medivir to present positive data at the annual meeting of the American College of Rheumatology.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Advocacy groups praise policy change towards reforming 340B and reducing drug costs for seniors.

Changes to 340B reimbursement will drastically lower out-of-pocket costs for Medicare beneficiaries.

Proton pump inhibitors may lead to an imbalance of Enterococcus bacteria and increase the risk of liver injury.

Glucose is crucial for the growth of brain cancer cells.

Approximately 1 in 10 people will experience a poorly healing wound, which can lead to amputations in patients with diabetes.

Norepinephrine may increase blood vessel growth in prostate cancer tumors.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Even beyond American Pharmacists Month, pharmacists deserve to be recognized for the important role they play in patient care.

The #APharmacistIs campaign aims to increase awareness about the value of pharmacists.

Tisagenlecleucel (Kyrmiah) shows promise as a treatment for diffuse large B-cell lymphoma.

HIV-positive children administered antiretroviral therapy have changes in their white matter brain tissue.

Novel methods to package, store, and dispose of opioids could fight the ongoing epidemic.

The addition of arsenic trioxide to standard therapy could triple glioblastoma survival.

Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

The application for acalabrutinib in mantle cell lymphoma was previously granted priority review, breakthrough therapy, and orphan drug designations, according to the FDA.

Medicare-insured patients with heart disease had the greatest access to PCSK9 inhibitors.